$21.48
-0.01-0.05%
最終更新: Apr 14, 11:53 AM
Benzinga
Benzinga
Benzinga
火曜日, 4 14
Benzinga
© 2026 Benzinga | All Rights Reserved
最新の Day One Biopharmaceutical インサイダー取引活動を追跡します。Day One Biopharmaceutical 株の最近の購入、売却、市場への影響について最新情報を入手してください。
インサイダー取引とは、役員、取締役、従業員などの企業内部関係者が自社の株式の取引を行う行為です。インサイダーの売買取引は、会社の将来の業績に対する彼らの信頼を知る貴重な洞察を提供します。
内部関係者らは、過去30日間に売買はなかったと報告している。
過去90日間にインサイダーによる売買はありませんでした。
| Feb 18, 2026 | Lauren Merendino | CHIEF COMMERCIAL OFFICER | 9.35K | $11.60 | -$67.45K | SELL-OPTIONS | 18.40% | 60.16K | Feb 15 - Feb 17 | View |
| Feb 18, 2026 | Adam Dubow | GEN COUNSEL & SECRETARY | 10.07K | $11.60 | -$74.19K | SELL-OPTIONS | 16.08% | 72.69K | Feb 15 - Feb 17 | View |
| Feb 18, 2026 | Charles N. York II | COO AND CFO | 17.31K | $11.60 | -$70.36K | SELL-OPTIONS | 5.87% | 312.02K | Feb 15 - Feb 17 | View |
| Feb 18, 2026 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 27.48K | $11.60 | -$179.34K | SELL-OPTIONS | 5.76% | 504.60K | Feb 15 - Feb 17 | View |
| Feb 18, 2026 | MICHAEL VASCONCELLES | HEAD RESEARCH AND DEV. | 4.40K | $11.60 | -$31.65K | SELL-OPTIONS | ∞ | 4.40K | Feb 15 - Feb 17 | View |
| Nov 18, 2025 | Adam Dubow | GEN COUNSEL & SECRETARY | 7.77K | $8.91 | -$38.50K | SELL-OPTIONS | 14.16% | 62.63K | Nov 15 - Nov 17 | View |
| Nov 18, 2025 | Charles N. York II | COO AND CFO | 12.81K | $8.91 | -$36.21K | SELL-OPTIONS | 4.55% | 294.71K | Nov 15 - Nov 17 | View |
| Nov 18, 2025 | Lauren Merendino | CHIEF COMMERCIAL OFFICER | 6.81K | $8.91 | -$33.22K | SELL-OPTIONS | 15.48% | 50.81K | Nov 15 - Nov 17 | View |
| Nov 18, 2025 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 15.80K | $8.91 | -$141.69K | SELL-OPTIONS | 1.01% | 1.59M | Nov 15 - Nov 17 | View |
| Aug 19, 2025 | Charles N. York II | COO AND CFO | 12.77K | $6.77 | -$27.79K | SELL-OPTIONS | 4.81% | 278.00K | Aug 15 - Aug 18 | View |
| Aug 19, 2025 | Adam Dubow | GEN COUNSEL & SECRETARY | 7.72K | $6.77 | -$29.54K | SELL-OPTIONS | 16.38% | 54.86K | Aug 15 - Aug 18 | View |
| Aug 19, 2025 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 15.63K | $6.77 | -$108.67K | SELL-OPTIONS | 1.01% | 1.57M | Aug 15 - Aug 18 | View |
| Aug 19, 2025 | Lauren Merendino | CHIEF COMMERCIAL OFFICER | 6.77K | $6.77 | -$25.48K | SELL-OPTIONS | 19.25% | 41.93K | Aug 15 - Aug 18 | View |
| May 19, 2025 | Lauren Merendino | CHIEF COMMERCIAL OFFICER | 6.61K | $6.26 | -$24.57K | SELL-OPTIONS | 23.15% | 35.16K | May 15 - May 16 | View |
| May 19, 2025 | Adam Dubow | GENERAL COUNSEL | 7.53K | $6.26 | -$28.49K | SELL-OPTIONS | 19.02% | 47.14K | May 15 - May 16 | View |
| May 19, 2025 | Charles N. York II | COO, CFO AND SECRETARY | 12.59K | $6.26 | -$26.80K | SELL-OPTIONS | 4.98% | 265.23K | May 15 - May 16 | View |
| May 19, 2025 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 17.72K | $6.26 | -$87.39K | SELL-OPTIONS | 1.90% | 952.76K | May 15 - May 16 | View |
| Feb 21, 2025 | Charles N. York II | COO, CFO AND SECRETARY | 12.51K | $11.96 | -$52.28K | SELL-OPTIONS | 5.21% | 252.64K | Feb 15 - Feb 18 | View |
| Feb 21, 2025 | Adam Dubow | GENERAL COUNSEL | 7.44K | $11.96 | -$55.58K | SELL-OPTIONS | 23.13% | 39.60K | Feb 15 - Feb 18 | View |
| Feb 21, 2025 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 19.64K | $11.96 | -$144.13K | SELL-OPTIONS | 2.15% | 935.04K | Feb 15 - Feb 18 | View |
| Dec 12, 2024 | Samuel Blackman | HEAD OF R&D | -30.00K | $13.31 | -$399.34K | SELL | -1.45% | 2.03M | Dec 10 | View |
| Nov 19, 2024 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 9.45K | $13.21 | -$139.42K | SELL-OPTIONS | 1.04% | 915.40K | Nov 15 - Nov 18 | View |
| Nov 19, 2024 | Samuel Blackman | HEAD OF R&D | 6.48K | $13.21 | -$29.14K | SELL-OPTIONS | 0.31% | 2.06M | Nov 15 - Nov 18 | View |
| Nov 19, 2024 | Adam Dubow | GENERAL COUNSEL | 5.23K | $13.21 | -$41.81K | SELL-OPTIONS | 19.44% | 32.16K | Nov 15 - Nov 18 | View |
| Nov 19, 2024 | Charles N. York II | COO, CFO AND SECRETARY | 7.65K | $13.21 | -$34.37K | SELL-OPTIONS | 3.29% | 240.13K | Nov 15 - Nov 18 | View |
| Nov 12, 2024 | Samuel Blackman | HEAD OF R&D | -28.25K | $16.15 | -$456.22K | SELL | -1.35% | 2.06M | Nov 08 - Nov 11 | View |
| Nov 08, 2024 | Samuel Blackman | HEAD OF R&D | -11.24K | $16.03 | -$180.29K | SELL | -0.54% | 2.09M | Nov 07 | View |
| Nov 04, 2024 | Samuel Blackman | HEAD OF R&D | -500.00 | $16.02 | -$8.01K | SELL | -0.02% | 2.10M | Oct 31 | View |
| Sep 12, 2024 | Samuel Blackman | HEAD OF R&D | -30.00K | $14.22 | -$426.68K | SELL | -1.41% | 2.10M | Sep 10 | View |
| Aug 19, 2024 | Adam Dubow | GENERAL COUNSEL | 5.20K | $14.00 | -$44.83K | SELL-OPTIONS | 23.92% | 26.93K | Aug 15 - Aug 16 | View |
| Aug 19, 2024 | Charles N. York II | COO, CFO AND SECRETARY | 7.62K | $14.00 | -$36.86K | SELL-OPTIONS | 3.39% | 232.49K | Aug 15 - Aug 16 | View |
| Aug 19, 2024 | Samuel Blackman | HEAD OF R&D | 6.45K | $14.00 | -$31.25K | SELL-OPTIONS | 0.30% | 2.13M | Aug 15 - Aug 16 | View |
| Aug 19, 2024 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 9.32K | $14.00 | -$149.52K | SELL-OPTIONS | 1.04% | 905.96K | Aug 15 - Aug 16 | View |
| Jul 17, 2024 | Samuel Blackman | HEAD OF R&D | -20.00K | $16.01 | -$320.23K | SELL | -0.93% | 2.12M | Jul 16 | View |
| Jun 21, 2024 | Saira Ramasastry | — | -10.00K | $13.19 | -$131.88K | SELL | -19.81% | 40.48K | Jun 21 | View |
| Jun 12, 2024 | Samuel Blackman | HEAD OF R&D | -30.00K | $12.62 | -$378.59K | SELL | -1.38% | 2.14M | Jun 10 | View |
| May 17, 2024 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 12.13K | $16.08 | -$126.59K | SELL-OPTIONS | 1.33% | 924.95K | May 15 - May 16 | View |
| May 17, 2024 | Samuel Blackman | HEAD OF R&D | 6.42K | $16.08 | -$36.45K | SELL-OPTIONS | 0.30% | 2.17M | May 15 - May 16 | View |
| May 17, 2024 | Charles N. York II | COO, CFO AND SECRETARY | 7.58K | $16.08 | -$43.01K | SELL-OPTIONS | 3.49% | 224.87K | May 15 - May 16 | View |
| May 17, 2024 | Adam Dubow | GENERAL COUNSEL | 5.15K | $16.08 | -$52.30K | SELL-OPTIONS | 31.03% | 21.73K | May 15 - May 16 | View |
| May 14, 2024 | Samuel Blackman | HEAD OF R&D | -10.00K | $16.37 | -$163.74K | SELL | -0.46% | 2.16M | May 10 | View |
| May 03, 2024 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -79.21K | $17.87 | -$1.42M | SELL | -7.98% | 912.83K | May 01 - May 03 | View |
| May 03, 2024 | Charles N. York II | COO, CFO AND SECRETARY | -60.46K | $17.88 | -$1.08M | SELL | -21.77% | 217.29K | May 01 - May 03 | View |
| Apr 22, 2024 | Samuel Blackman | HEAD OF R&D | -10.00K | $16.02 | -$160.16K | SELL | -0.46% | 2.17M | Apr 18 | View |
| Mar 26, 2024 | Samuel Blackman | HEAD OF R&D | -10.00K | $16.01 | -$160.06K | SELL | -0.46% | 2.18M | Mar 25 | View |
| Mar 13, 2024 | Samuel Blackman | HEAD OF R&D | -30.00K | $15.24 | -$457.31K | SELL | -1.35% | 2.19M | Mar 11 | View |
| Feb 28, 2024 | Samuel Blackman | HEAD OF R&D | -20.00K | $16.11 | -$322.17K | SELL | -0.89% | 2.22M | Feb 27 | View |
| Feb 20, 2024 | Adam Dubow | GENERAL COUNSEL | 5.16K | $15.25 | -$49.43K | SELL-OPTIONS | 45.13% | 16.59K | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Charles N. York II | COO, CFO AND SECRETARY | 7.58K | $15.25 | -$40.65K | SELL-OPTIONS | 2.81% | 277.75K | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Samuel Blackman | HEAD OF RESEARCH AND DEVELOPME | 6.43K | $15.25 | -$34.43K | SELL-OPTIONS | 0.29% | 2.24M | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 12.38K | $15.25 | -$116.11K | SELL-OPTIONS | 1.26% | 992.04K | Feb 15 - Feb 16 | View |
| Nov 17, 2023 | Charles N. York II | COO, CFO AND SECRETARY | 2.67K | $11.69 | -$11.18K | SELL-OPTIONS | 1.00% | 270.17K | Nov 15 - Nov 16 | View |
| Nov 17, 2023 | Adam Dubow | GENERAL COUNSEL | 8.29K | $11.69 | -$62.11K | SELL-OPTIONS | 263.83% | 11.43K | Nov 15 - Nov 16 | View |
| Nov 17, 2023 | Samuel Blackman | HEAD RESEARCH AND DEVELOPME | 1.92K | $11.69 | -$8.29K | SELL-OPTIONS | 0.09% | 2.24M | Nov 15 - Nov 16 | View |
| Nov 17, 2023 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 5.21K | $11.69 | -$36.32K | SELL-OPTIONS | 0.53% | 979.65K | Nov 15 - Nov 16 | View |
| Oct 20, 2023 | AI Day LLCAccess Industries Holdings LLCACCESS INDUSTRIES MANAGEMENT LLCLen Blavatnik | 10% OWNER | 1.48M | $10.15 | $14.98M | BUY | 12.88% | 12.93M | Oct 18 - Oct 20 | View |
| Aug 17, 2023 | Charles N. York II | COO, CFO AND SECRETARY | 2.70K | $13.86 | -$12.78K | SELL-OPTIONS | 1.02% | 267.50K | Aug 15 - Aug 17 | View |
| Aug 17, 2023 | Samuel Blackman | HEAD RESEARCH AND DEVELOPME | 1.96K | $13.86 | -$9.26K | SELL-OPTIONS | 0.09% | 2.24M | Aug 15 - Aug 17 | View |
| Aug 17, 2023 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 5.32K | $13.86 | -$41.52K | SELL-OPTIONS | 0.55% | 974.45K | Aug 15 - Aug 17 | View |
| Jun 12, 2023 | AI Day LLCAccess Industries Holdings LLCACCESS INDUSTRIES MANAGEMENT LLCLen Blavatnik | 10% OWNER | 769.23K | $13.00 | $10.00M | BUY | 7.20% | 11.45M | Jun 09 | View |
| Jun 07, 2023 | Samuel Blackman | CHIEF MEDICAL OFFICER | -1.23K | $16.00 | -$19.66K | SELL | -0.05% | 2.23M | Jun 05 | View |
| May 17, 2023 | Charles N. York II | COO, CFO AND SECRETARY | 2.67K | $13.12 | -$12.53K | SELL-OPTIONS | 1.02% | 264.80K | May 15 - May 16 | View |
| May 17, 2023 | Samuel Blackman | CHIEF MEDICAL OFFICER | 1.93K | $13.12 | -$9.08K | SELL-OPTIONS | 0.09% | 2.24M | May 15 - May 16 | View |
| May 17, 2023 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 5.21K | $13.12 | -$40.73K | SELL-OPTIONS | 0.36% | 1.46M | May 15 - May 16 | View |
| Mar 14, 2023 | Samuel Blackman | CHIEF MEDICAL OFFICER | -10.00K | $18.05 | -$180.48K | SELL | -0.45% | 2.23M | Mar 10 | View |
| Mar 08, 2023 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -12.50K | $20.01 | -$250.11K | SELL | -0.85% | 1.46M | Mar 07 | View |
| Mar 03, 2023 | Papanek Julie Grant | DIRECTOR | -25.00K | $18.61 | -$465.30K | SELL | -0.86% | 2.88M | Mar 01 | View |
| Feb 21, 2023 | Charles N. York II | COO, CFO AND SECRETARY | -9.38K | $20.03 | -$187.79K | SELL | -3.45% | 262.13K | Feb 17 | View |
| Feb 17, 2023 | Charles N. York II | COO, CFO AND SECRETARY | 2.69K | $19.57 | -$18.20K | SELL-OPTIONS | 1.00% | 271.50K | Feb 15 - Feb 16 | View |
| Feb 17, 2023 | Samuel Blackman | CHIEF MEDICAL OFFICER | 1.95K | $19.57 | -$13.19K | SELL-OPTIONS | 0.09% | 2.24M | Feb 15 - Feb 16 | View |
| Feb 17, 2023 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 5.29K | $19.57 | -$59.15K | SELL-OPTIONS | 0.36% | 1.47M | Feb 15 - Feb 16 | View |
| Feb 13, 2023 | Samuel Blackman | CHIEF MEDICAL OFFICER | -10.00K | $20.07 | -$200.66K | SELL | -0.44% | 2.24M | Feb 10 | View |
| Feb 03, 2023 | Papanek Julie Grant | DIRECTOR | -25.00K | $21.23 | -$530.79K | SELL | -0.85% | 2.90M | Feb 01 | View |
| Jan 24, 2023 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -12.50K | $22.00 | -$274.99K | SELL | -0.85% | 1.46M | Jan 23 | View |
| Jan 23, 2023 | Charles N. York II | COO, CFO AND SECRETARY | -10.00K | $22.75 | -$227.52K | SELL | -3.59% | 268.81K | Jan 20 | View |
| Jan 11, 2023 | Samuel Blackman | CHIEF MEDICAL OFFICER | -10.00K | $22.86 | -$228.64K | SELL | -0.44% | 2.25M | Jan 10 | View |
| Jan 04, 2023 | Papanek Julie Grant | DIRECTOR | -25.00K | $20.65 | -$516.15K | SELL | -0.85% | 2.93M | Jan 03 | View |
| Dec 22, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -12.50K | $20.32 | -$253.97K | SELL | -0.84% | 1.47M | Dec 21 | View |
| Dec 22, 2022 | Charles N. York II | COO, CFO AND SECRETARY | -10.00K | $20.07 | -$200.65K | SELL | -3.49% | 276.50K | Dec 20 | View |
| Dec 12, 2022 | Papanek Julie Grant | DIRECTOR | -4.36K | $22.08 | -$96.21K | SELL | -0.15% | 2.95M | Dec 08 | View |
| Dec 05, 2022 | Papanek Julie Grant | DIRECTOR | -10.00K | $21.65 | -$216.48K | SELL | -0.34% | 2.96M | Dec 01 - Dec 02 | View |
| Dec 05, 2022 | Samuel Blackman | CHIEF MEDICAL OFFICER | -10.00K | $21.45 | -$214.53K | SELL | -0.44% | 2.26M | Dec 01 | View |
| Nov 22, 2022 | Charles N. York II | COO, CFO AND SECRETARY | -10.00K | $20.76 | -$207.57K | SELL | -3.37% | 286.50K | Nov 21 | View |
| Nov 22, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -12.50K | $20.76 | -$259.48K | SELL | -0.83% | 1.49M | Nov 21 | View |
| Nov 17, 2022 | Charles N. York II | COO, CFO AND SECRETARY | 945.00 | $21.46 | -$9.23K | SELL-OPTIONS | 0.32% | 296.50K | Nov 15 - Nov 16 | View |
| Nov 17, 2022 | Samuel Blackman | CHIEF MEDICAL OFFICER | 810.00 | $21.46 | -$8.09K | SELL-OPTIONS | 0.04% | 2.27M | Nov 15 - Nov 16 | View |
| Nov 17, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 2.05K | $21.46 | -$32.47K | SELL-OPTIONS | 0.14% | 1.50M | Nov 15 - Nov 16 | View |
| Nov 03, 2022 | Charles N. York II | COO, CFO AND SECRETARY | -10.00K | $20.03 | -$200.31K | SELL | -3.29% | 294.40K | Nov 01 | View |
| Nov 03, 2022 | Papanek Julie Grant | DIRECTOR | -10.00K | $20.03 | -$200.28K | SELL | -0.34% | 2.97M | Nov 01 - Nov 02 | View |
| Nov 03, 2022 | Samuel Blackman | CHIEF MEDICAL OFFICER | -10.00K | $20.00 | -$200.05K | SELL | -0.44% | 2.27M | Nov 01 | View |
| Nov 03, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -12.50K | $20.03 | -$250.36K | SELL | -0.83% | 1.50M | Nov 01 | View |
| Oct 05, 2022 | Charles N. York II | COO, CFO AND SECRETARY | -10.00K | $20.05 | -$200.47K | SELL | -3.18% | 304.40K | Oct 03 | View |
| Oct 05, 2022 | Papanek Julie Grant | DIRECTOR | -10.00K | $20.03 | -$200.31K | SELL | -0.14% | 7.39M | Oct 03 - Oct 04 | View |
| Oct 05, 2022 | Samuel Blackman | CHIEF MEDICAL OFFICER | -10.00K | $19.99 | -$199.85K | SELL | -0.44% | 2.28M | Oct 03 | View |
| Oct 05, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -12.50K | $20.05 | -$250.65K | SELL | -0.82% | 1.51M | Oct 03 | View |
| Sep 22, 2022 | Canaan XI LPCanaan Partners XI LLC | 10% OWNER | -2.11M | $18.55 | -$11.38M | SELL | -23.28% | 6.96M | Sep 21 | View |
| Sep 22, 2022 | Papanek Julie Grant | DIRECTOR | -2.11M | $18.55 | -$11.38M | SELL | -23.28% | 6.97M | Sep 21 | View |
| Sep 20, 2022 | Papanek Julie Grant | DIRECTOR | -340.70K | $20.44 | -$6.96M | SELL | -3.62% | 9.08M | Sep 16 - Sep 20 | View |
| Sep 20, 2022 | Canaan XI LPCanaan Partners XI LLC | 10% OWNER | -340.70K | $20.44 | -$6.96M | SELL | -3.62% | 9.08M | Sep 16 - Sep 20 | View |
| Sep 15, 2022 | Papanek Julie Grant | DIRECTOR | -245.04K | $23.76 | -$5.82M | SELL | -2.54% | 9.42M | Sep 13 - Sep 15 | View |
| Sep 15, 2022 | Canaan XI LPCanaan Partners XI LLC | 10% OWNER | -245.04K | $23.76 | -$5.82M | SELL | -2.54% | 9.42M | Sep 13 - Sep 15 | View |
| Sep 15, 2022 | Julie Papanek Grant | DIRECTOR | -5.00K | $23.82 | -$119.11K | SELL | -0.05% | 10.10M | Sep 02 | View |
| Sep 06, 2022 | Charles N. York II | COO, CFO AND SECRETARY | -10.00K | $23.25 | -$232.48K | SELL | -3.08% | 314.40K | Sep 01 | View |
| Sep 06, 2022 | Julie Papanek Grant | DIRECTOR | -5.00K | $23.27 | -$116.36K | SELL | -0.05% | 10.11M | Sep 01 | View |
| Sep 06, 2022 | Samuel Blackman | CHIEF MEDICAL OFFICER | -10.00K | $23.25 | -$232.45K | SELL | -0.43% | 2.29M | Sep 01 | View |
| Sep 06, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -12.50K | $23.25 | -$290.58K | SELL | -0.81% | 1.52M | Sep 01 | View |
| Sep 06, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -12.50K | $23.25 | -$290.58K | SELL | -0.81% | 1.52M | Sep 01 | View |
| Aug 17, 2022 | Samuel Blackman | CHIEF MEDICAL OFFICER | 2.62K | $24.31 | -$22.88K | SELL-OPTIONS | 0.11% | 2.30M | Aug 15 - Aug 16 | View |
| Aug 17, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | 6.68K | $24.31 | -$97.31K | SELL-OPTIONS | 0.44% | 1.53M | Aug 15 - Aug 16 | View |
| Aug 17, 2022 | Charles N. York II | COO, CFO AND SECRETARY | 3.04K | $24.31 | -$26.47K | SELL-OPTIONS | 0.94% | 324.40K | Aug 15 - Aug 16 | View |
| Aug 08, 2022 | Julie Papanek Grant | DIRECTOR | -10.00K | $20.00 | -$200.00K | SELL | -0.10% | 10.11M | Aug 04 - Aug 05 | View |
| Aug 05, 2022 | Charles N. York II | COO, CFO AND SECRETARY | -10.00K | $20.05 | -$200.54K | SELL | -3.02% | 321.37K | Aug 04 | View |
| Aug 05, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -12.50K | $20.00 | -$250.02K | SELL | -0.81% | 1.53M | Aug 04 | View |
| Aug 03, 2022 | Samuel Blackman | CHIEF MEDICAL OFFICER | -10.00K | $16.88 | -$168.81K | SELL | -0.43% | 2.30M | Aug 01 | View |
| Jul 20, 2022 | Charles N. York II | COO, CFO AND SECRETARY | -2.50K | $20.00 | -$50.00K | SELL | -0.75% | 331.37K | Jul 18 | View |
| Jul 20, 2022 | Julie Papanek Grant | DIRECTOR | -2.60K | $20.00 | -$52.00K | SELL | -0.03% | 10.12M | Jul 18 | View |
| Jul 20, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -2.60K | $20.00 | -$52.00K | SELL | -0.17% | 1.54M | Jul 18 | View |
| Jul 12, 2022 | Julie Papanek Grant | DIRECTOR | -1.24K | $20.00 | -$24.84K | SELL | -0.01% | 10.13M | Jul 08 | View |
| Jul 12, 2022 | Charles N. York II | COO, CFO AND SECRETARY | -1.42K | $20.00 | -$28.32K | SELL | -0.42% | 333.87K | Jul 08 | View |
| Jul 12, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -1.79K | $20.00 | -$35.90K | SELL | -0.12% | 1.54M | Jul 08 | View |
| Jul 06, 2022 | Charles N. York II | COO, CFO AND SECRETARY | -2.28K | $20.00 | -$45.58K | SELL | -0.68% | 335.28K | Jul 01 - Jul 05 | View |
| Jul 06, 2022 | Julie Papanek Grant | DIRECTOR | -1.80K | $20.00 | -$36.00K | SELL | -0.39% | 463.20K | Jul 01 - Jul 05 | View |
| Jul 06, 2022 | Samuel Blackman | CHIEF MEDICAL OFFICER | -10.00K | $18.72 | -$187.16K | SELL | -0.43% | 2.31M | Jul 01 | View |
| Jul 06, 2022 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | -2.60K | $20.00 | -$52.06K | SELL | -0.17% | 1.54M | Jul 01 - Jul 05 | View |
| Jun 22, 2022 | Atlas Venture Opportunity Fund II LPAtlas Venture Fund XI LPAtlas Venture Associates XI LPAtlas Venture Associates XI LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | 766.67K | $15.00 | $11.50M | BUY | 77.33% | 1.76M | Jun 17 | View |
| Jun 22, 2022 | Michael Gladstone | DIRECTOR | 766.67K | $15.00 | $11.50M | BUY | ∞ | 766.67K | Jun 17 | View |
| Jun 21, 2022 | AI Day LLCAccess Industries Holdings LLCACCESS INDUSTRIES MANAGEMENT LLCLen Blavatnik | 10% OWNER | 1.20M | $15.00 | $18.00M | BUY | 12.65% | 10.68M | Jun 17 | View |
| Jun 17, 2022 | Samuel Blackman | CHIEF MEDICAL OFFICER | -50.00K | $16.26 | -$813.16K | SELL | -2.11% | 2.32M | Jun 15 | View |
| Jan 20, 2022 | AI Day LLCAccess Industries Holdings LLCACCESS INDUSTRIES MANAGEMENT LLCLen Blavatnik | 10% OWNER | 106.86K | $14.52 | $1.55M | BUY | 1.14% | 9.48M | Jan 18 - Jan 20 | View |
| Jan 05, 2022 | Samuel Blackman | CHIEF MEDICAL OFFICER | -10.00K | $17.10 | -$171.02K | SELL | -0.42% | 2.37M | Jan 03 | View |
| Dec 09, 2021 | TAKEDA PHARMACEUTICAL CO LTDTakeda Pharmaceuticals USA IncMILLENNIUM PHARMACEUTICALS INCTakeda Ventures Inc | 10% OWNER | -297.27K | $18.49 | -$5.50M | SELL | -4.63% | 6.12M | Dec 07 - Dec 08 | View |
| Dec 07, 2021 | TAKEDA PHARMACEUTICAL CO LTDTakeda Pharmaceuticals USA IncMILLENNIUM PHARMACEUTICALS INCTakeda Ventures Inc | 10% OWNER | -110.21K | $18.10 | -$1.99M | SELL | -1.69% | 6.42M | Dec 03 - Dec 06 | View |
| Dec 03, 2021 | Samuel Blackman | CHIEF MEDICAL OFFICER | -10.00K | $17.22 | -$172.24K | SELL | -0.72% | 1.38M | Oct 22 - Dec 01 | View |
| Jun 03, 2021 | AI Day LLCAccess Industries Holdings LLCACCESS INDUSTRIES MANAGEMENT LLCLen Blavatnik | 10% OWNER | 9.38M | $16.00 | $14.00M | BUY | ∞ | 9.38M | Jun 01 | View |
| Jun 02, 2021 | Julie Papanek Grant | DIRECTOR | 7.49M | $16.00 | $208.00K | BUY | 201.83% | 11.20M | Jun 01 | View |
| Jun 02, 2021 | Atlas Venture Fund XI LPAtlas Venture Associates Opportunity I LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates XI LPAtlas Venture Associates XI LLC | 10% OWNER | 9.00M | $16.00 | $8.00M | BUY | ∞ | 250.00K | Jun 01 | View |
| Jun 02, 2021 | Canaan XI LPCanaan Partners XI LLC | 10% OWNER | 7.49M | $16.00 | $208.00K | BUY | 230.75% | 10.74M | Jun 01 | View |
| Jun 01, 2021 | John Josey | DIRECTOR | 7.00K | $16.00 | $112.00K | BUY | 10.72% | 72.29K | Jun 01 | View |
| Jun 01, 2021 | Daniel Becker | DIRECTOR | 5.00K | $16.00 | $80.00K | BUY | ∞ | 5.00K | Jun 01 | View |